FDA approves second microbiome-based C. difficile therapy
Nat Rev Drug Discov
.
2023 Jun;22(6):436.
doi: 10.1038/d41573-023-00081-1.
Author
Asher Mullard
PMID:
37165093
DOI:
10.1038/d41573-023-00081-1
No abstract available
Publication types
News
MeSH terms
Clostridioides difficile*
Clostridium Infections* / drug therapy
Humans
Microbiota*